Valuation (31%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -28.80 | 19.98 |
| PEG Ratio (TTM) | -0.29 | 1.98 |
| P/S Ratio (TTM) | N/A | 1.39 |
| P/B Ratio (TTM) | 2.12 | 5.63 |
| P/FCF Ratio (TTM) | N/A | 14.10 |
| Price to 5YR AVG Earnings Ratio | 21.40 | 21.29 |
| Price to 5YR AVG FCF Ratio | 40.27 | 15.54 |
Profitability (10%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -3.41% | 4.88% |
| ROE (TTM) | -6.94% | 32.44% |
| Net Profit Margin (TTM) | -2.36% | 4.71% |
| ROIC 5YR AVG | 12.40% | 14.61% |
Growth (15%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -128.57% | 4.01% | -76.99% |
| Revenue | -2.00% | 3.04% | 0.87% |
| Net Income | -128.64% | 3.47% | -76.68% |
| Cash Flow | 239.58% | -14.41% | -33.68% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.45 | 1.62 |
| Quick Ratio (TTM) | 0.80 | 0.89 |
| D/E Ratio (TTM) | 0.40 | 1.25 |
| Interest Coverage (TTM) | -7.11 | 19.28 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 4.07 | 3.56 |
| LTL to 5YR AVG FCF | 7.24 | 6.94 |
| Shares Outstanding Growth 5YR AVG | -0.29% | -2.25% |